Immunome (IMNM) EBIT (2019 - 2026)
Immunome (IMNM) posted EBIT of -$59.3 million for Q1 2026, up 18.57% on a QoQ basis from -$72.9 million in Q4 2025, and down 32.92% year-over-year from -$88.5 million in Q1 2025.
Immunome (IMNM) EBIT (2019 - 2026) Analysis & Trends
Immunome's EBIT history runs 8 years deep, the most recent figure standing at -$59.3 million for Q1 2026.
- Quarterly EBIT fell 32.92% year-over-year to -$59.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$238.8 million (down 9.48% YoY) and the FY2025 annual result came in at -$224.1 million, up 26.71% from the prior year.
- EBIT was -$59.3 million for Q1 2026 at Immunome, up from -$72.9 million in the prior quarter.
- Across five years, EBIT topped out at -$4.5 million in Q1 2023 and bottomed at -$132.3 million in Q1 2024.
- A 5-year average of -$43.3 million and a median of -$44.6 million in 2025 frame the typical range for EBIT.
- Annual changes were most pronounced in 2024 — EBIT plunged 2859.05% — and 2025, when it soared 66.26%.
- Immunome's EBIT stood at -$7.8 million in 2022, then slumped by 1115.53% to -$94.7 million in 2023, then grew by 12.34% to -$83.0 million in 2024, then grew by 12.18% to -$72.9 million in 2025, then increased by 18.57% to -$59.3 million in 2026.
- Business Quant data shows IMNM's EBIT at -$59.3 million in Q1 2026, -$72.9 million in Q4 2025, and -$60.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Immunome | 2.51 Bn | 1.93 Bn | - | -59.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.33 Mn |
| Dec 31, 2025 | -72.86 Mn |
| Sep 30, 2025 | -60.14 Mn |
| Jun 30, 2025 | -46.48 Mn |
| Mar 31, 2025 | -44.64 Mn |
| Dec 31, 2024 | -82.97 Mn |
| Sep 30, 2024 | -50.52 Mn |
| Jun 30, 2024 | -40.01 Mn |
| Mar 31, 2024 | -132.30 Mn |
| Dec 31, 2023 | -94.65 Mn |
| Sep 30, 2023 | -4.63 Mn |
| Jun 30, 2023 | -5.77 Mn |
| Mar 31, 2023 | -4.47 Mn |
| Dec 31, 2022 | -7.79 Mn |
| Sep 30, 2022 | -8.53 Mn |
| Jun 30, 2022 | -8.93 Mn |
| Mar 31, 2022 | -11.65 Mn |
| Dec 31, 2021 | -7.84 Mn |
| Sep 30, 2021 | -7.72 Mn |
| Jun 30, 2021 | -5.74 Mn |